Conexeu Sciences Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CNXU | CLGN | OCC.AX | MDWD | CELU | MDXG | |
|---|---|---|---|---|---|---|
| Market cap | 68.45M | 13.01M | 151.18M | 183.33M | 26.25M | 466.96M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -4.2 | -10.8 | -23.6 | -6.2 | -1.4 | 30.0 |
| Price/book | 10.4 | 2.1 | 4.4 | 5.1 | -0.7 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −83.01% | −80.60% | −52.21% | −21.24% | −52.13% | −59.17% |
| Today | −6.72% | +2.92% | +2.78% | +6.05% | −1.02% | −1.54% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All CNXU news ›Insider Buying: Conexeu Sciences (NASDAQ:CNXU) Director Purchases $499,998.00 in Stock
Posted by Kim Johansen on Oct 19th, 2026 CNXU stock traded up $0.26 during trading on Monday, reaching $3.32. 365,524 shares of the company were exchanged, compared to its average volume of 192,955. The firm’s 50 day moving average is…
Conexeu Sciences Announces $5 Million Private Placement Led By Existing Shareholders, Management And Directors
TradingView Conexeu Sciences Announces $5 Million Private Placement Led By Existing Shareholders, Management And Directors
Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Published on 10/06/2026 at 08:31 am EDT The Company is conducting manufacturing, testing, and preclinical work intended to support its planned FDA 510(k) submission. Conexeu remains on track to make the submission in the first calendar…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com1
- stocktitan.net1
- themarketsdaily.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.